+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psychedelic Drugs Market Analysis & Forecast to 2024-2034

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5923231
The global psychedelic drugs market size was estimated to be USD 1.81 billion in 2023 and is expected to reach at USD 6.39 billion by 2034 with a CAGR of 12.17% during the forecast period 2024-2034. Rising prevalence of mental health disorders, increased demand for managing heightened stress, anxiety, & other mental conditions, growing awareness regarding the treatment of mental disorders, surge in research & development efforts, rising acceptance of psychedelic drugs for depression, an escalating incidence of substance addiction, increase in the number of clinical trial products, growing awareness initiatives conducted by both private & government institutes are some of the key factors boosting the market growth.

Growing awareness initiatives conducted by both private & government institutes is predicted to boost the market growth during the forecast period. Psychedelic drugs encompass a range of chemical substances, such as lysergic acid diethylamide (LSD) and compounds derived from plants. These substances possess the capacity to alter or intensify sensory perceptions, cognitive processes, and energy levels, and there are reports suggesting their role in facilitating spiritual experiences. For instance, in May 2022, The Mental Health Foundation organized Mental Health Awareness Week with a focus on the theme of 'loneliness.' The intention was to delve into the phenomenon of loneliness, its impact on mental health, and to encourage collective efforts in communities to diminish feelings of loneliness.

By drug type, psilocybin was the highest revenue-grossing segment in the global psychedelic drugs market in 2023 owing to a substantial quantity of clinical trials being conducted on psilocybin to assess its therapeutic efficacy. Additionally, ketamine is predicted to grow at the fastest CAGR during the forecast period owing to the increasing utilization of ketamine for depression treatment and the rising introduction of innovative therapeutic alternatives. For instance, in October 2022, Numinus Wellness Inc, a company dedicated to advancing mental health care through innovative treatments and safe, evidence-based psychedelic-assisted therapies, has initiated the Ketamine for Chronic and Serious Medical Illness Program. This newly launched program is expected to be initially implemented at Numinus' clinics located in Utah, British Columbia, and Quebec. The company has plans to extend the program to additional clinics in the subsequent months.

By source, synthetic psychedelic drugs was the highest revenue-grossing segment in the global psychedelic drugs market in 2023 owing to a significant demand for this source attributed to the selective generation of compounds & active pharmaceutical products, facilitating the creation of innovative drug formulations, and increased collaboration among prominent market players. For instance, in January 2022, Dalriada Drug Discovery has entered into a collaboration with atai Life Sciences to create advanced small molecule therapies derived from psychedelics and related compounds, specifically for mental health disorders. The collaboration aims to build a varied pipeline of new chemical entities (NCE) that surpass current compounds in both clinical and preclinical stages of development, targeting the enhancement of treatments for these disorders. The initial phase of the company's efforts will concentrate on developing innovative compounds directed at the serotonin 5-HT2A receptor, with subsequent attention on additional central nervous system (CNS) targets. Additionally, natural psychedelic drugs is predicted to grow at the fastest CAGR during the forecast period owing to the rising fascination with natural sources and the potential advantages they offer. The exploration of natural sources for their therapeutic potential in addressing mental health disorders like depression, anxiety, and post-traumatic stress disorder (PTSD) is becoming more prevalent.

By route of administrations, oral was the highest revenue-grossing segment in the global psychedelic drugs market in 2023 as it is more convenient and involves less invasiveness compared to injectable administration. Additionally, injectable is predicted to grow at the fastest CAGR during the forecast period owing to the increasing use of injectables is observed in situations requiring immediate effects, accompanied by a rising number of treatment options in the development pipeline. For instance, in December 2023, MAPS Public Benefit Corp. submitted an application to the U.S. Food and Drug Administration seeking approval for the use of the psychedelic drug MDMA, commonly known as Ecstasy, in combination with therapy for the treatment of post-traumatic stress disorder. If approved, this would mark the inaugural instance of such a treatment.

By application, post-traumatic stress disorder was the highest revenue-grossing segment in the global psychedelic drugs market in 2023 owing to the growing awareness of the effectiveness of psychedelic drugs in alleviating symptoms associated with PTSD and other mental health issues, coupled with an expansion in research and development activities. For instance, in March 2022, Researchers from the University of California shared findings and follow-up information from a phase 3 clinical trial involving a psychedelic substance, 3,4 methylenedioxymethamphetamine (MDMA), in conjunction with psychotherapy for addressing PTSD. The initial data indicated the efficacy of the therapy, even among challenging cases like individuals with substance use disorders. Additionally, treatment resistant depression is predicted to grow at the fastest CAGR during the forecast period owing to the increasing number of clinical trials and studies underway to investigate the potential of psychedelic drugs, reflecting shifting lifestyle trends and a rising prevalence of major depression disorders.

By distribution channel, hospital pharmacy was the highest revenue-grossing segment in the global psychedelic drugs market in 2023 owing to the growing awareness of mental health issues among the public, a surge in the prescription of psychedelic drugs by medical practitioners, and an increasing trend of collaborations among market players. For instance, in July 2022, Havn Life has partnered with the Canadian non-profit TheraPsil and the UK-based organization Drug Science to embark on the most extensive medical psilocybin and data initiative to date. This project aims to offer a secure supply of psilocybin to patients with medical requirements. Additionally, retail pharmacy is predicted to grow at the fastest CAGR during the forecast period owing to the increase in awareness about psychedelic drugs, accompanied by a growing utilization of these substances for specific medical indications.

By end-user, mental health center was the highest revenue-grossing segment in the global psychedelic drugs market in 2023 owing to a widespread adoption of psychedelic drugs in mental health centers for the treatment of mental illnesses, along with a significant increase in company expansions and the establishment of psychedelic treatment centers. For instance, in March 2022, Delic Corporation, headquartered in Canada, has extended the reach of its Ketamine Wellness Centers (KWC) to include new locations in Salt Lake City and Reno. These centers offer treatment options that incorporate their FDA-approved SPRAVATO (esketamine). Additionally, hospitals is predicted to grow at the fastest CAGR during the forecast period owing to the growing influx of patients seeking mental health treatment at hospitals, coupled with a rising number of prescribed medications.

North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of mental health disorders, a surge in the demand for psychedelic drugs, and a growing awareness of mental health issues that necessitate treatment with psychedelic drugs. For instance, in October 2022, The Canadian Government organized Mental Illness Awareness Week, a nationwide campaign designed to educate and inform Canadians about the actualities of mental illness. This initiative provides an opportunity for the public to dispel misconceptions surrounding mental health and enhance overall understanding of the subject. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the research and development activities related to psychedelic drugs, an increasing number of clinical trial procedures, and a surge in government initiatives in this field. For instance, in July 2023, In Australia, medications containing psychedelic substances like psilocybin and MDMA can only be prescribed by a licensed psychiatrist for specific disorders. The Therapeutic Goods Administration (TGA) is anticipated to authorize the prescription of MDMA specifically for post-traumatic stress disorder treatment.

Segmentation: Psychedelic Drugs Market Report 2023 - 2034

Psychedelic Drugs Market Analysis & Forecast by Drug Type 2023 - 2034 (Revenue USD Bn)

  • Gamma Hydroxybutyric Acid (GHB)
  • 3,4-MethylEnedioxyMethamphetamine
  • Lysergic Acid Diethylamide (LSD)
  • Psilocybin
  • Ketamine
  • Others

Psychedelic Drugs Market Analysis & Forecast by Source 2023 - 2034 (Revenue USD Bn)

  • Synthetic Psychedelic Drugs
  • Natural Psychedelic Drugs

Psychedelic Drugs Market Analysis & Forecast by Route of Administrations 2023 - 2034 (Revenue USD Bn)

  • Nasal
  • Oral
  • Rectal
  • Injectable
  • Transdermal

Psychedelic Drugs Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

  • Treatment Resistant Depression
  • Post-traumatic Stress Disorder
  • Panic Disorders
  • Opiate Addiction
  • Narcolepsy
  • Others

Psychedelic Drugs Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Others

Psychedelic Drugs Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Hospitals
  • Mental Health Center
  • Others

Psychedelic Drugs Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Psychedelic Drugs Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Psychedelic Drugs Market: Drug Type Estimates & Trend Analysis
7.1. Drug Type Segment Opportunity Analysis
7.2. Gamma Hydroxybutyric Acid (GHB)
7.2.1. Gamma Hydroxybutyric Acid (GHB) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. 3,4-MethylEnedioxyMethamphetamine
7.3.1. 3,4-MethylEnedioxyMethamphetamine Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Lysergic Acid Diethylamide (LSD)
7.4.1. Lysergic Acid Diethylamide (LSD) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Psilocybin
7.5.1. Psilocybin Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Ketamine
7.6.1. Ketamine Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.7. Others
7.7.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Psychedelic Drugs Market: Source Estimates & Trend Analysis
8.1. Source Segment Opportunity Analysis
8.2. Synthetic Psychedelic Drugs
8.2.1. Synthetic Psychedelic Drugs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Natural Psychedelic Drugs
8.3.1. Natural Psychedelic Drugs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Psychedelic Drugs Market: Route of Administration Estimates & Trend Analysis
9.1. Route of Administration Segment Opportunity Analysis
9.2. Nasal
9.2.1. Nasal Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Oral
9.3.1. Oral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Rectal
9.4.1. Rectal Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.5. Injectable
9.5.1. Injectable Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.6. Transdermal
9.6.1. Transdermal Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Psychedelic Drugs Market: Application Estimates & Trend Analysis
10.1. Application Segment Opportunity Analysis
10.2. Treatment Resistant Depression
10.2.1. Treatment Resistant Depression Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.3. Post-traumatic Stress Disorder
10.3.1. Post-traumatic Stress Disorder Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.4. Panic Disorders
10.4.1. Panic Disorders Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.5. Opiate Addiction
10.5.1. Opiate Addiction Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.6. Narcolepsy
10.6.1. Narcolepsy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.7. Others
10.7.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11. Psychedelic Drugs Market: Distribution Channel Estimates & Trend Analysis
11.1. Distribution Channel Segment Opportunity Analysis
11.2. Retail Pharmacy
11.2.1. Retail Pharmacy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3. Hospital Pharmacy
11.3.1. Hospital Pharmacy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.4. Others
11.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12. Psychedelic Drugs Market: End-user Estimates & Trend Analysis
12.1. End-user Segment Opportunity Analysis
12.2. Hospitals
12.2.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12.3. Mental Health Center
12.3.1. Mental Health Center Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12.4. Others
12.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
13. Regional Market Analysis
13.1. Regional Market Opportunity Analysis
14. North America Psychedelic Drugs Market
14.1. North America Psychedelic Drugs Market
14.1.1. North America Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. North America Psychedelic Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. North America Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
14.1.4. North America Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
14.1.5. North America Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.1.6. North America Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.1.7. North America Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.1.8. North America Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. U.S. Global Psychedelic Drugs Market
14.2.1. U.S. Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. U.S. Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
14.2.3. U.S. Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
14.2.4. U.S. Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.2.5. U.S. Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.2.6. U.S. Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2.7. U.S. Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. Canada Global Psychedelic Drugs Market
14.3.1. Canada Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Canada Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
14.3.3. Canada Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
14.3.4. Canada Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.3.5. Canada Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.3.6. Canada Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3.7. Canada Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. Europe Global Psychedelic Drugs Market
15.1. Europe Global Psychedelic Drugs Market
15.1.1. Europe Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. Europe Psychedelic Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. Europe Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
15.1.4. Europe Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
15.1.5. Europe Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.1.6. Europe Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.7. Europe Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.1.8. Europe Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. Germany Global Psychedelic Drugs Market
15.2.1. Germany Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. Germany Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
15.2.3. Germany Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
15.2.4. Germany Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.2.5. Germany Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.6. Germany Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2.7. Germany Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. UK Global Psychedelic Drugs Market
15.3.1. UK Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. UK Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
15.3.3. UK Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
15.3.4. UK Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.3.5. UK Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.6. UK Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3.7. UK Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. France Global Psychedelic Drugs Market
15.4.1. France Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. France Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
15.4.3. France Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
15.4.4. France Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.4.5. France Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.4.6. France Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4.7. France Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.5. Spain Global Psychedelic Drugs Market
15.5.1. Spain Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.5.2. Spain Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
15.5.3. Spain Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
15.5.4. Spain Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.5.5. Spain Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.5.6. Spain Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.5.7. Spain Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.6. Italy Global Psychedelic Drugs Market
15.6.1. Italy Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.6.2. Italy Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
15.6.3. Italy Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
15.6.4. Italy Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.6.5. Italy Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.6.6. Italy Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.6.7. Italy Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.7. Rest of Europe Global Psychedelic Drugs Market
15.7.1. Rest of Europe Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.7.2. Rest of Europe Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
15.7.3. Rest of Europe Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
15.7.4. Rest of Europe Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.7.5. Rest of Europe Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.7.6. Rest of Europe Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.7.7. Rest of Europe Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Asia Pacific Global Psychedelic Drugs Market
16.1. Asia Pacific Global Psychedelic Drugs Market
16.1.1. Asia Pacific Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.1.2. Asia Pacific Psychedelic Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
16.1.3. Asia Pacific Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
16.1.4. Asia Pacific Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
16.1.5. Asia Pacific Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.1.6. Asia Pacific Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.1.7. Asia Pacific Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.1.8. Asia Pacific Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.2. Japan Global Psychedelic Drugs Market
16.2.1. Japan Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.2.2. Japan Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
16.2.3. Japan Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
16.2.4. Japan Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.2.5. Japan Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.2.6. Japan Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.2.7. Japan Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.3. China Global Psychedelic Drugs Market
16.3.1. China Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.3.2. China Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
16.3.3. China Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
16.3.4. China Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.3.5. China Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.3.6. China Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.3.7. China Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.4. India Global Psychedelic Drugs Market
16.4.1. India Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.4.2. India Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
16.4.3. India Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
16.4.4. India Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.4.5. India Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.4.6. India Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.4.7. India Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.5. South Korea Global Psychedelic Drugs Market
16.5.1. South Korea Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.5.2. South Korea Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
16.5.3. South Korea Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
16.5.4. South Korea Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.5.5. South Korea Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.5.6. South Korea Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.5.7. South Korea Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.6. Australia Global Psychedelic Drugs Market
16.6.1. Australia Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.6.2. Australia Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
16.6.3. Australia Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
16.6.4. Australia Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.6.5. Australia Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.6.6. Australia Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.6.7. Australia Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.7. Rest of Asia Pacific Global Psychedelic Drugs Market
16.7.1. Rest of Asia Pacific Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.7.2. Rest of Asia Pacific Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
16.7.3. Rest of Asia Pacific Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
16.7.4. Rest of Asia Pacific Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.7.5. Rest of Asia Pacific Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.7.6. Rest of Asia Pacific Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.7.7. Rest of Asia Pacific Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17. Latin America Global Psychedelic Drugs Market
17.1. Latin America Global Psychedelic Drugs Market
17.1.1. Latin America Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.1.2. Latin America Psychedelic Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
17.1.3. Latin America Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
17.1.4. Latin America Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
17.1.5. Latin America Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.1.6. Latin America Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.1.7. Latin America Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
17.1.8. Latin America Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.2. Brazil Global Psychedelic Drugs Market
17.2.1. Brazil Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.2.2. Brazil Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
17.2.3. Brazil Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
17.2.4. Brazil Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.2.5. Brazil Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.2.6. Brazil Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
17.2.7. Brazil Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.3. Mexico Global Psychedelic Drugs Market
17.3.1. Mexico Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.3.2. Mexico Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
17.3.3. Mexico Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
17.3.4. Mexico Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.3.5. Mexico Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.3.6. Mexico Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
17.3.7. Mexico Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.4. Argentina Global Psychedelic Drugs Market
17.4.1. Argentina Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.4.2. Argentina Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
17.4.3. Argentina Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
17.4.4. Argentina Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.4.5. Argentina Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.4.6. Argentina Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
17.4.7. Argentina Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.5. Rest of Latin America Global Psychedelic Drugs Market
17.5.1. Rest of Latin America Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.5.2. Rest of Latin America Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
17.5.3. Rest of Latin America Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
17.5.4. Rest of Latin America Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
17.5.5. Rest of Latin America Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.5.6. Rest of Latin America Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
17.5.7. Rest of Latin America Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18. MEA Global Psychedelic Drugs Market
18.1. MEA Global Psychedelic Drugs Market
18.1.1. MEA Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.1.2. MEA Psychedelic Drugs Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
18.1.3. MEA Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
18.1.4. MEA Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
18.1.5. MEA Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
18.1.6. MEA Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.1.7. MEA Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
18.1.8. MEA Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18.2. GCC Global Psychedelic Drugs Market
18.2.1. GCC Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.2.2. GCC Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
18.2.3. GCC Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
18.2.4. GCC Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
18.2.5. GCC Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.2.6. GCC Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
18.2.7. GCC Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18.3. South Africa Global Psychedelic Drugs Market
18.3.1. South Africa Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.3.2. South Africa Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
18.3.3. South Africa Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
18.3.4. South Africa Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
18.3.5. South Africa Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.3.6. South Africa Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
18.3.7. South Africa Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18.4. Rest of MEA Global Psychedelic Drugs Market
18.4.1. Rest of MEA Psychedelic Drugs Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.4.2. Rest of MEA Psychedelic Drugs Market Size and Forecast, By Drug Type, 2023-2034 (Revenue USD Bn)
18.4.3. Rest of MEA Psychedelic Drugs Market Size and Forecast, By Source, 2023-2034 (Revenue USD Bn)
18.4.4. Rest of MEA Psychedelic Drugs Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
18.4.5. Rest of MEA Psychedelic Drugs Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.4.6. Rest of MEA Psychedelic Drugs Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
18.4.7. Rest of MEA Psychedelic Drugs Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
19. Competitor Analysis
19.1. Company Market Share Analysis, 2023
19.2. Major Recent Developments
20. Company Profiles
20.1. NeonMind BioSciences
20.2. Cybin Corp.
20.3. Pfizer Inc.
20.4. Usona Institute
20.5. Numinus
20.6. Jazz Pharmaceuticals
20.7. Havn Life
20.8. Revive Therapeutics
20.9. Seelos Therapeutics
20.10. PharmaTher Holdings Ltd
20.11. NRx Pharmaceuticals Inc.
20.12. Mind Medicine
20.13. Other Prominent Players
21. Conclusion22. Recommendations

Companies Mentioned

  • Medtronic
  • Changzhou Ankang Medical Instruments
  • Locamed
  • Johnson & Johnson
  • Frankenman International Ltd
  • Zhejiang Geyi Medical Instrument
  • Infiniti Medical
  • Reach Surgical
  • Surkonmed

Table Information